跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
EMTRICITABINA/TENOFOVIR ALAFENAMIDA LUPIN 200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
EMTRICITABINA/TENOFOVIR ALAFENAMIDA LUPIN 200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Lupin Europe Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 10, 2026
Approval ID
3f4dd548864fe2e4
Company
Lupin Europe Gmbh
Type
Standard
Approval Details
Approval Id
3f4dd548864fe2e4
Drug Cima Aemps Name
EMTRICITABINA/TENOFOVIR ALAFENAMIDA LUPIN 200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
91593
Holder Company Name
Lupin Europe Gmbh
Marketing Company Name
Lupin Europe Gmbh
Holder Company Detail Path
/organization/lupin-europe-gmbh
Marketing Company Detail Path
/organization/lupin-europe-gmbh
Authorization Date
2026-09-10
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
200 mg/25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Lupin Europe Gmbh
Company Detail Path
/organization/lupin-europe-gmbh
Company Information
Pharmaceutical Company Name
Lupin Europe GmbH
Country Name
Germany
City Name
frankfurt am main,hessen,country_de
Address
Hanauer Landstr. 139-143
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 10, 2026
Approval ID
3f4dd548864fe2e4
Type
Standard
Back to CIMA-AEMPS Approvals
EMTRICITABINA/TENOFOVIR ALAFENAMIDA LUPIN 200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details